Titre : Linuron

Linuron : Questions médicales fréquentes

Termes MeSH sélectionnés :

Developing Countries
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Linuron : Questions médicales les plus fréquentes", "headline": "Linuron : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Linuron : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-10", "dateModified": "2025-03-05", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Linuron" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Phénylurées", "url": "https://questionsmedicales.fr/mesh/D010671", "about": { "@type": "MedicalCondition", "name": "Phénylurées", "code": { "@type": "MedicalCode", "code": "D010671", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.703" } } }, "about": { "@type": "MedicalCondition", "name": "Linuron", "alternateName": "Linuron", "code": { "@type": "MedicalCode", "code": "D008044", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Dirk Springael", "url": "https://questionsmedicales.fr/author/Dirk%20Springael", "affiliation": { "@type": "Organization", "name": "Division of Soil and Water Management, KU Leuven, Leuven, Belgium." } }, { "@type": "Person", "name": "Başak Öztürk", "url": "https://questionsmedicales.fr/author/Ba%C5%9Fak%20%C3%96zt%C3%BCrk", "affiliation": { "@type": "Organization", "name": "Division of Soil and Water Management, KU Leuven, Leuven, Belgium." } }, { "@type": "Person", "name": "Mikael Pedersen", "url": "https://questionsmedicales.fr/author/Mikael%20Pedersen", "affiliation": { "@type": "Organization", "name": "Research group for Analytical Food Chemistry, National Food Institute, Technical University of Denmark, 2800 Kgs, Lyngby, Denmark." } }, { "@type": "Person", "name": "Johannes Werner", "url": "https://questionsmedicales.fr/author/Johannes%20Werner", "affiliation": { "@type": "Organization", "name": "Department of Biological Oceanography, Leibniz Institute for Baltic Sea Research, Rostock, Germany." } }, { "@type": "Person", "name": "Boyke Bunk", "url": "https://questionsmedicales.fr/author/Boyke%20Bunk", "affiliation": { "@type": "Organization", "name": "Bioinformatics Department, Leibniz Institute DSMZ, German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Economic freedom, inclusive growth, and financial development: A heterogeneous panel analysis of developing countries.", "datePublished": "2023-07-11", "url": "https://questionsmedicales.fr/article/37432915", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0288346" } }, { "@type": "ScholarlyArticle", "name": "Ensuring environmental inclusion in developing countries: the role of macroeconomic policies.", "datePublished": "2022-12-07", "url": "https://questionsmedicales.fr/article/36474034", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11356-022-24596-z" } }, { "@type": "ScholarlyArticle", "name": "Evaluating the quality of health technology assessment reports in a developing country.", "datePublished": "2023-07-31", "url": "https://questionsmedicales.fr/article/37553743", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.26719/emhj.22.017" } }, { "@type": "ScholarlyArticle", "name": "Investigating the impact of air pollution in selected African developing countries.", "datePublished": "2023-04-17", "url": "https://questionsmedicales.fr/article/37067712", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11356-023-26998-z" } }, { "@type": "ScholarlyArticle", "name": "The national health program for vitamin D supplementation in a developing country.", "datePublished": "2023-01-20", "url": "https://questionsmedicales.fr/article/36963898", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.clnesp.2023.01.012" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés chimiques organiques", "item": "https://questionsmedicales.fr/mesh/D009930" }, { "@type": "ListItem", "position": 3, "name": "Hydrocarbures", "item": "https://questionsmedicales.fr/mesh/D006838" }, { "@type": "ListItem", "position": 4, "name": "Hydrocarbures cycliques", "item": "https://questionsmedicales.fr/mesh/D006844" }, { "@type": "ListItem", "position": 5, "name": "Hydrocarbures aromatiques", "item": "https://questionsmedicales.fr/mesh/D006841" }, { "@type": "ListItem", "position": 6, "name": "Dérivés du benzène", "item": "https://questionsmedicales.fr/mesh/D001555" }, { "@type": "ListItem", "position": 7, "name": "Phénylurées", "item": "https://questionsmedicales.fr/mesh/D010671" }, { "@type": "ListItem", "position": 8, "name": "Linuron", "item": "https://questionsmedicales.fr/mesh/D008044" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Linuron - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Linuron", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-07", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Linuron", "description": "Comment diagnostiquer une exposition au linuron ?\nQuels tests peuvent détecter le linuron dans le corps ?\nQuels symptômes indiquent une intoxication au linuron ?\nY a-t-il des tests spécifiques pour les effets du linuron ?\nComment évaluer le risque d'exposition au linuron ?", "url": "https://questionsmedicales.fr/mesh/D008044?mesh_terms=Developing+Countries&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Linuron", "description": "Quels sont les symptômes d'une exposition aiguë au linuron ?\nPeut-on avoir des effets chroniques après exposition au linuron ?\nQuels signes cliniques sont associés à une intoxication au linuron ?\nComment différencier les symptômes du linuron d'autres toxines ?\nLes symptômes du linuron peuvent-ils varier selon l'âge ?", "url": "https://questionsmedicales.fr/mesh/D008044?mesh_terms=Developing+Countries&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Linuron", "description": "Comment prévenir l'exposition au linuron ?\nQuelles sont les recommandations pour les travailleurs exposés au linuron ?\nLes femmes enceintes doivent-elles éviter le linuron ?\nQuelles mesures de sécurité doivent être prises lors de l'utilisation du linuron ?\nComment informer le public sur les dangers du linuron ?", "url": "https://questionsmedicales.fr/mesh/D008044?mesh_terms=Developing+Countries&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Linuron", "description": "Quel traitement est recommandé en cas d'intoxication au linuron ?\nY a-t-il un antidote spécifique pour le linuron ?\nComment traiter les irritations cutanées causées par le linuron ?\nQuels soins d'urgence sont nécessaires en cas d'exposition au linuron ?\nLes traitements varient-ils selon la voie d'exposition au linuron ?", "url": "https://questionsmedicales.fr/mesh/D008044?mesh_terms=Developing+Countries&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Linuron", "description": "Quelles complications peuvent survenir après une exposition au linuron ?\nLe linuron peut-il affecter la reproduction ?\nY a-t-il des risques de cancer associés au linuron ?\nComment le linuron affecte-t-il le système nerveux ?\nLes enfants sont-ils plus vulnérables aux effets du linuron ?", "url": "https://questionsmedicales.fr/mesh/D008044?mesh_terms=Developing+Countries&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Linuron", "description": "Quels sont les principaux facteurs de risque d'exposition au linuron ?\nL'environnement peut-il influencer l'exposition au linuron ?\nLes personnes ayant des antécédents médicaux sont-elles à risque ?\nLes conditions de travail affectent-elles le risque d'exposition au linuron ?\nLes habitudes de vie influencent-elles l'exposition au linuron ?", "url": "https://questionsmedicales.fr/mesh/D008044?mesh_terms=Developing+Countries&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une exposition au linuron ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique d'exposition et des tests biologiques spécifiques." } }, { "@type": "Question", "name": "Quels tests peuvent détecter le linuron dans le corps ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses d'urine et de sang peuvent révéler la présence de linuron." } }, { "@type": "Question", "name": "Quels symptômes indiquent une intoxication au linuron ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des nausées, des vertiges et des irritations cutanées." } }, { "@type": "Question", "name": "Y a-t-il des tests spécifiques pour les effets du linuron ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de fonction hépatique et rénale peuvent être effectués pour évaluer les effets." } }, { "@type": "Question", "name": "Comment évaluer le risque d'exposition au linuron ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'évaluation du risque se fait par l'analyse des conditions de travail et des habitudes." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une exposition aiguë au linuron ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes aigus incluent des maux de tête, des nausées et des troubles respiratoires." } }, { "@type": "Question", "name": "Peut-on avoir des effets chroniques après exposition au linuron ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une exposition prolongée peut entraîner des problèmes respiratoires et dermatologiques." } }, { "@type": "Question", "name": "Quels signes cliniques sont associés à une intoxication au linuron ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les signes cliniques incluent des éruptions cutanées, des troubles gastro-intestinaux et des vertiges." } }, { "@type": "Question", "name": "Comment différencier les symptômes du linuron d'autres toxines ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Un historique d'exposition et des tests spécifiques aident à différencier les symptômes." } }, { "@type": "Question", "name": "Les symptômes du linuron peuvent-ils varier selon l'âge ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants et les personnes âgées peuvent présenter des symptômes plus graves." } }, { "@type": "Question", "name": "Comment prévenir l'exposition au linuron ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des équipements de protection individuelle et suivre les protocoles de sécurité." } }, { "@type": "Question", "name": "Quelles sont les recommandations pour les travailleurs exposés au linuron ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les travailleurs doivent suivre des formations sur la manipulation sécurisée des produits chimiques." } }, { "@type": "Question", "name": "Les femmes enceintes doivent-elles éviter le linuron ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il est conseillé aux femmes enceintes d'éviter l'exposition au linuron en raison des risques." } }, { "@type": "Question", "name": "Quelles mesures de sécurité doivent être prises lors de l'utilisation du linuron ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Porter des gants, des masques et travailler dans des zones bien ventilées." } }, { "@type": "Question", "name": "Comment informer le public sur les dangers du linuron ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des campagnes de sensibilisation et des brochures d'information peuvent être mises en place." } }, { "@type": "Question", "name": "Quel traitement est recommandé en cas d'intoxication au linuron ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement inclut l'élimination de l'exposition et des soins symptomatiques." } }, { "@type": "Question", "name": "Y a-t-il un antidote spécifique pour le linuron ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas d'antidote spécifique pour le linuron, le traitement est symptomatique." } }, { "@type": "Question", "name": "Comment traiter les irritations cutanées causées par le linuron ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les irritations cutanées peuvent être traitées avec des crèmes apaisantes et des antihistaminiques." } }, { "@type": "Question", "name": "Quels soins d'urgence sont nécessaires en cas d'exposition au linuron ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les soins d'urgence incluent le lavage de la peau et l'administration d'oxygène si nécessaire." } }, { "@type": "Question", "name": "Les traitements varient-ils selon la voie d'exposition au linuron ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements diffèrent selon qu'il s'agit d'une exposition cutanée, orale ou respiratoire." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après une exposition au linuron ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des troubles respiratoires chroniques et des problèmes dermatologiques." } }, { "@type": "Question", "name": "Le linuron peut-il affecter la reproduction ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Des études suggèrent que le linuron peut avoir des effets néfastes sur la reproduction." } }, { "@type": "Question", "name": "Y a-t-il des risques de cancer associés au linuron ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des recherches sont en cours pour évaluer le potentiel cancérigène du linuron." } }, { "@type": "Question", "name": "Comment le linuron affecte-t-il le système nerveux ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Une exposition prolongée peut entraîner des troubles neurologiques et des effets cognitifs." } }, { "@type": "Question", "name": "Les enfants sont-ils plus vulnérables aux effets du linuron ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants peuvent être plus sensibles aux effets toxiques du linuron en raison de leur développement." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque d'exposition au linuron ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les travailleurs agricoles et ceux manipulant des pesticides sont les plus exposés." } }, { "@type": "Question", "name": "L'environnement peut-il influencer l'exposition au linuron ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la proximité des zones agricoles et l'utilisation de pesticides augmentent le risque." } }, { "@type": "Question", "name": "Les personnes ayant des antécédents médicaux sont-elles à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes avec des problèmes respiratoires préexistants peuvent être plus à risque." } }, { "@type": "Question", "name": "Les conditions de travail affectent-elles le risque d'exposition au linuron ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des conditions de travail non sécurisées augmentent le risque d'exposition au linuron." } }, { "@type": "Question", "name": "Les habitudes de vie influencent-elles l'exposition au linuron ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des habitudes comme le jardinage sans protection peuvent augmenter l'exposition." } } ] } ] }

Sources (10000 au total)

Evaluating the quality of health technology assessment reports in a developing country.

No single method of health technology assessment (HTA) can meet all the policy- and decision-making needs in a country. However, there should be minimum criteria for performing HTA worldwide, and many... This study aimed to assess the quality of HTA reports in the Islamic Republic of Iran.... We examined all the HTA research reports published by the Iranian HTA office up to 2020, using the International Network of Agencies for Health Technology Assessment checklist for quality assessment.... A total of 97 reports were examined, of which only 10.0% provided complete and appropriate contact details for further information and 5.6% clearly stated a conflict of interest. In 87.78% of the repo... We recommend that minimum standards be established for the HTA process so that healthcare policy- and decision-makers can make reliable decisions on the basis of the HTA reports....

The national health program for vitamin D supplementation in a developing country.

Previous studies have reported a high frequency of vitamin D deficiency (VDD) among different age groups in Iran.... In this study, the current coverage, status of vitamin D supplement taking, and program efficacy have been evaluated by the Office of Nutrition Department Society in Iran since 2014.... This study was conducted in collaboration with the International UNESCO center for Health-Related Basic Sciences and Human Nutrition and the Office of Nutrition Department Society. Sixty three medical... Quantitative analysis showed that availability coverage was 74.96% and 77.56% and accessibility was 80.70% and 83.26% in elderly and middle-aged subjects, respectively in 2018. The acceptability was a... The frequency of taking vitamin D supplements was 27.0% in Iran in 2018. The frequency of taking of vitamin D supplements among vitamin D deficient group (serum vitamin D levels <19.99 ng/ml) was 43.6...

Outcomes of burns patients in a developing country: A single centre's experience.

Pelonomi Tertiary Hospital is the only hospital in the Free State Province with a burns unit. We do not have official data to assess our performance in the management of burns.... To determine the Lethal Area 50 (LA50) index for the Pelonomi Tertiary Hospital's burns unit. Furthermore, to determine the morbidity that affects burns patients at the institution, and the factors as... We used Redcap to capture demographic and clinical data of burn patients admitted to our institution between January 2014 and December 2018. Logistic regression was used to determine significant predi... Our study had a male preponderance, with 59.7% (601) male, 39.9% (401) female and 0.4% (4) missing sex. We had a mean age of 19.4 years, of which 53.38% (n=537) were paediatric patients and 46.32% (n=... The epidemiology of burn patients and working conditions at Pelonomi Tertiary Hospital are similar to other burn units in the country; however, our mortality rate is higher than at most centres. The L...

Technical aspects of inguino scrotal hernia surgery in developing countries.

Technical aspects of inguinoscrotal herniorrhaphy performed in low to middle income countries (LMICs) are described here to help surgeons who will operate on these challenging hernias in austere setti... Technical considerations related to operative repair were delineated with the consensus of 7 surgeons with extensive experience in inguinoscrotal hernia repair in LMICs. Important steps and illustrati... The authors have cumulatively performed over 1775 inguinoscrotal Lichtenstein operations in LMICs. While dedicated, reliable, long-term follow-up is unavailable from LMICs, one author reports outcomes... There is a difference between inguinal hernias found in LMICs and those seen in high-income countries with larger, chronic, and more technically challenging pathology. The consequences of intra-operat...